Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,084 | 433 | 89.3% |
| Travel and Lodging | $976.54 | 2 | 8.6% |
| Education | $136.43 | 6 | 1.2% |
| Grant | $100.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $1,902 | 36 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,398 | 71 | $0 (2023) |
| Abbott Laboratories | $1,172 | 17 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $951.00 | 43 | $0 (2024) |
| Amgen Inc. | $797.86 | 39 | $0 (2024) |
| Boston Scientific Corporation | $676.84 | 24 | $0 (2024) |
| PFIZER INC. | $660.24 | 44 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $539.84 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $320.30 | 25 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $298.95 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $424.92 | 16 | Boston Scientific Corporation ($100.00) |
| 2023 | $626.09 | 31 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($127.98) |
| 2022 | $1,284 | 54 | Boston Scientific Corporation ($208.55) |
| 2021 | $478.42 | 26 | BIOTRONIK INC. ($147.12) |
| 2020 | $562.27 | 32 | Novartis Pharmaceuticals Corporation ($89.40) |
| 2019 | $2,376 | 98 | Janssen Pharmaceuticals, Inc ($345.16) |
| 2018 | $3,155 | 86 | BIOTRONIK INC. ($1,245) |
| 2017 | $2,391 | 99 | Novartis Pharmaceuticals Corporation ($352.41) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/21/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $52.72 | General |
| Category: Rheumatology | ||||||
| 06/27/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 05/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Not Applicable | ||||||
| 04/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiology | ||||||
| 04/05/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/27/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Cardiology | ||||||
| 01/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: DIABETES | ||||||
| 01/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/05/2024 | Boston Scientific Corporation | — | Grant | Cash or cash equivalent | $100.00 | General |
| Category: General - Structural Heart_IC | ||||||
| 01/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/27/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.72 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/20/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: Not Applicable | ||||||
| 11/13/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $20.46 | General |
| Category: Medical Device | ||||||
| 11/02/2023 | ShockWave Medical, Inc | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: Lithoplasty | ||||||
| 10/20/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $54.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/12/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardiology | ||||||
| 09/12/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,925 | 2,291 | $469,160 | $109,464 |
| 2022 | 19 | 1,865 | 2,322 | $614,178 | $139,424 |
| 2021 | 21 | 1,775 | 2,189 | $673,859 | $142,941 |
| 2020 | 21 | 2,177 | 2,730 | $725,686 | $165,308 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 348 | 380 | $139,255 | $31,526 | 22.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 160 | 164 | $83,232 | $20,528 | 24.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 95 | 95 | $52,660 | $12,311 | 23.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 80 | 89 | $54,023 | $11,361 | 21.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 117 | 121 | $23,232 | $5,624 | 24.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 84 | $18,144 | $5,108 | 28.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $22,120 | $4,933 | 22.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 428 | 574 | $14,893 | $3,186 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $11,330 | $2,582 | 22.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 48 | 108 | $9,288 | $2,301 | 24.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 58 | 132 | $8,448 | $2,067 | 24.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 223 | 226 | $9,492 | $2,047 | 21.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 24 | 26 | $5,710 | $1,300 | 22.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 13 | $4,056 | $1,196 | 29.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 157 | 161 | $3,864 | $1,006 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $3,120 | $832.92 | 26.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 11 | 11 | $2,816 | $697.62 | 24.8% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 12 | 14 | $2,625 | $648.89 | 24.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 12 | 12 | $444.00 | $115.92 | 26.1% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 12 | 12 | $408.00 | $93.81 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 349 | 383 | $145,521 | $30,320 | 20.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 180 | 185 | $106,216 | $25,252 | 23.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 94 | 105 | $63,735 | $15,538 | 24.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 109 | 110 | $64,879 | $15,241 | 23.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 53 | 53 | $34,804 | $7,793 | 22.4% |
About Dr. David Blick, MD
Dr. David Blick, MD is a Cardiovascular Disease healthcare provider based in Blue Springs, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699729202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Blick, MD has received a total of $11,297 in payments from pharmaceutical and medical device companies, with $424.92 received in 2024. These payments were reported across 442 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($10,084).
As a Medicare-enrolled provider, Blick has provided services to 7,742 Medicare beneficiaries, totaling 9,532 services with total Medicare billing of $557,138. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Interventional Cardiology
- Location Blue Springs, MO
- Active Since 05/19/2006
- Last Updated 09/11/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1699729202
Products in Payments
- XARELTO (Drug) $1,398
- ENTRESTO (Drug) $891.10
- ELIQUIS (Drug) $650.78
- Corlanor (Drug) $458.61
- Repatha (Biological) $339.25
- JARDIANCE (Drug) $329.91
- LifeVest (Device) $298.95
- Vascepa (Drug) $297.04
- BRILINTA (Drug) $269.45
- MULTAQ (Drug) $242.28
- VERQUVO (Drug) $235.87
- PRADAXA (Drug) $209.93
- Optis Coronary Imaging System (Device) $194.65
- CHANTIX (Drug) $184.25
- Asahi Fielder coronary guide wire (Device) $164.52
- KENGREAL (Drug) $162.37
- WATCHMAN (Device) $158.39
- VYNDAQEL (Drug) $145.51
- Assurity Pacemaker (Device) $139.24
- AVVIGO Guidance System (Device) $121.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.